- Clumber
- https://jobcop.ca/employer/a-systematic-review-of-methandrostenolone/
-
In June 2023, the FDA formally withdrew approval for oxandrolone for all indications, stating that possible adverse effects of the drug were sufficiently serious to warrant removal from the US market.
- Joined on
2026-04-01
Block a user
Sort